参考文献/References:
1 Mathers CD, Boerma T, Ma Fat D. Global and regional causes of death. Br Med Bull, 2009, 92: 7-32.
2 Kleindorfer D, Lindsell CJ, Brass L, et al. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke, 2008, 39(3): 924-928.
3 Calvert JW, Gundewar S, Jha S, et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes, 2008, 57(3): 696-705.
4 Selvin E, Hirsch AT. Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999 2004. Atherosclerosis, 2008, 201(2): 425-433.
5 Jiang T, Yu JT, Zhu XC, et al. Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy. Br J Pharmacol, 2014, 171(13): 3146-3157.
6 Takata F, Dohgu S, Matsumoto J, et al. Metformin induces up-regulation of blood brain barrier functions by activating AMP-activated protein kinase in rat brain microvascular endothelial cells. Biochem Biophys Res Commun. 2013, 433(4): 586-590.
7 Liu Y, Tang G, Li Y, et al. Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion. J Neuroinflammation, 2014, 11: 177.
8 Jin Q, Cheng J, Liu Y, et al. Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke. Brain Behav Immun, 2014, 40: 131-142.
9 Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. Clin Invest, 2001, 108(8): 1167-1174.
10 Martin-Montalvo A, Mercken EM, Mitchell SJ, et al. Metformin improves healthspan and lifespan in mice. Nat Commun, 2013, 4: 2192.
11 O’Neill LA, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature, 2013, 493(7432): 346-355.
12 Mantovani A, Biswas SK, Galdiero MR, et al. Macrophage plasticity and polarization in tissue repair and remodelling. Pathol, 2013, 229(2): 176-185.
13 Hu X, Li P, Guo Y, et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke, 2012, 43(11): 3063-3070.
14 Kato Y, Koide N, Komatsu T, et al. Metformin attenuates production of nitric oxide in response to lipopolysaccharide by inhibiting MyD88-independent pathway. Horm Metab Res, 2010, 42(9): 632-636.
15 Hattori Y, Suzuki K, Hattori S, et al. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension, 2006, 47(6): 1183-1188.
16 Greenwood J, Mason JC. Statins and the vascular endothelial inflammatory response. Trends Immunol, 2007, 28(2): 88-98.
17 Strecker JK, Sevimli S, Schilling M, et al. Effects of G-CSF treatment on neutrophil mobilization and neurological outcome after transient focal ischemia. Exp Neurol, 2010, 222(1): 108-113.
18 Diamanti-Kandarakis E, Paterakis T, Alexandraki K, et al. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod, 2006, 21(6): 1426-1431.
19 Lemeer S, Heck AJ. The phosphoproteomics data explosion. Curr Opin Chem Biol, 2009, 13(4): 414-420.
20 Khang R, Park C, Shin JH. The biguanide metformin alters phosphoproteomic profilingin mouse brain. Neuroscience Letters, 2014, 579: 145-150.
21 Formentini L, Pereira MP, S nchez-enizoL. et al. In vivo inhibition of the mitochon-drial H+-ATP synthase in neurons promotes metabolic preconditioning. EMBO, 2014, 33(7): 762-778.
22 Dulovic M, Jovanovic M, Xilouri M, et al. The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro. Neurobiol Dis, 2014, 63: 1-11.
23 Venna VR, Li J, Hammond MD, et al. Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke. Eur J Neurosci, 2014, 39(12): 2129-2138.
24 Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med, 1999, 222(3): 236-245.
25 Abd-Elsameea AA, Moustaf AA, Mohamed AM. Modulation of the oxidative stress by metformin in the cerebrum of rats exposed to global cerebral ischemia and ischemia/reperfusion. Eur Rev Med Pharmacol Sci, 2014, 18(16): 2387-2392.
26 Harada S, Fujita-Hamabe W, Tokuyama S. The importance of regulation of blood glucose levels through activation of peripheral 5’-AMP-activated protein kinase on ischemic neuronal damage. Brain Res, 2010, 1351:254-263.
27 Li J,Benashski SE,Venna VR, et al. Effects of metformin in experimental stroke. Stroke, 2010, 41(2): 2645-2652.
28 Li W, Qu Z, Prakash R, et al. Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats. Brain Res, 2013, 1541: 106-114.